These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[X]
|
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2012
|
|
OR
|
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Large Accelerated Filer
|
[ ]
|
Accelerated Filer
|
[ ]
|
|
|
Non-accelerated Filer
|
[ ]
|
Smaller Reporting Company
|
[X]
|
|
|
(Do not check if smaller reporting company)
|
||||
|
|
Page
|
|
|
|
||
|
FINANCIAL STATEMENTS.
|
3
|
|
|
|
||
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
11
|
|
|
|
||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
13
|
|
|
|
||
|
CONTROLS AND PROCEDURES.
|
13
|
|
|
|
||
|
|
||
|
|
||
|
RISK FACTORS.
|
14
|
|
|
|
||
|
EXHIBITS.
|
14
|
|
|
15
|
||
|
16
|
||
|
March 31,
2012
$
(unaudited)
|
December 31,
2011
$
|
|
|
ASSETS
|
||
|
Current Assets
|
||
|
Cash
|
207,562
|
320,178
|
|
Prepaid expenses and deposits
|
5,752
|
7,575
|
|
Total Assets
|
213,314
|
327,753
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
||
|
Current Liabilities
|
||
|
Accounts payable and accrued liabilities
|
18,748
|
6,509
|
|
Accounts payable and accrued liabilities – related party
|
22,616
|
12,137
|
|
Due to related parties
|
300,000
|
300,000
|
|
Total Current Liabilities
|
341,364
|
318,646
|
|
Convertible debenture, net of discount of $9,926 and $12,669, respectively
|
490,074
|
487,331
|
|
Total Liabilities
|
831,438
|
805,977
|
|
Stockholders’ Deficit
|
||
|
Preferred Stock
|
||
|
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
|
||
|
Issued and outstanding: nil preferred shares
|
–
|
–
|
|
Class A Preferred Stock
|
||
|
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
|
||
|
Issued and outstanding: 7,500,000 preferred shares, respectively
|
7,500
|
7,500
|
|
Common Stock
Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share
Issued and outstanding: 347,380,000 common shares, respectively
|
347,380
|
347,380
|
|
Additional paid-in capital
|
(345,427)
|
(345,427)
|
|
Deficit accumulated during the development stage
|
(627,577)
|
(487,677)
|
|
Total Stockholders’ Deficit
|
(618,124)
|
(478,224)
|
|
Total Liabilities and Stockholders’ Deficit
|
213,314
|
327,753
|
|
For the Three
Months Ended
March 31,
2012
$
|
For the Three
Months Ended
March 31,
2011
$
|
Accumulated from
November 3, 2008
(date of inception)
to March 31,
2012
$
|
|
|
Revenue
|
–
|
–
|
–
|
|
Operating Expenses
|
|||
|
Consulting fees
|
100,500
|
20,000
|
281,000
|
|
General and administrative
|
16,967
|
605
|
54,054
|
|
Management fees
|
–
|
7,500
|
43,727
|
|
Professional fees
|
8,500
|
15,000
|
113,106
|
|
Transfer agent fees
|
–
|
518
|
17,938
|
|
Total Operating Expenses
|
125,967
|
43,623
|
509,825
|
|
Loss Before Other Expense
|
(125,967)
|
(43,623)
|
(509,825)
|
|
Other Expenses
|
|||
|
Accretion expense
|
2,743
|
–
|
6,874
|
|
Gain on settlement of debt
|
–
|
–
|
(24,552)
|
|
Impairment of intangible assets
|
–
|
–
|
92,538
|
|
Interest expense
|
11,190
|
3,519
|
42,892
|
| Total Other Expenses |
13,933
|
3,519
|
117,752
|
|
Net Income (Loss) for the Period
|
(139,900)
|
(47,142)
|
(627,577)
|
|
Net Income (Loss) Per Share, Basic and Diluted
|
–
|
–
|
|
|
Weighted Average Shares Outstanding
|
347,380,000
|
538,200,000
|
|
For the Three Months Ended
March 31,
2012
$
|
For the Three Months Ended
March 31,
2011
$
|
Accumulated from
November 3, 2008
(date of inception)
to March 31,
2012
$
|
|
|
Operating Activities
|
|||
|
Net income (loss) for the period
|
(139,900)
|
(47,142)
|
(627,577)
|
|
Adjustment to reconcile net loss to cash used in operating activities:
|
|||
|
Accretion expense
|
2,743
|
–
|
6,874
|
|
Gain on settlement of debt
|
–
|
–
|
(24,552)
|
|
Impairment of intangible asset
|
–
|
–
|
92,538
|
|
Stock-based compensation
|
–
|
–
|
2,227
|
|
Shares issued for management fees
|
–
|
–
|
7,000
|
|
Changes in operating assets and liabilities:
|
|||
|
|
|||
|
Prepaid expense and deposits
|
1,823
|
–
|
(5,752)
|
|
Accounts payable and accrued liabilities
|
12,239
|
13,665
|
45,339
|
|
Accounts payable and accrued liabilities - related
|
10,479
|
–
|
23,577
|
|
Due to related parties
|
–
|
4,500
|
11,965
|
|
Net Cash Used in Operating Activities
|
(112,616)
|
(28,977)
|
(468,361)
|
|
Investing Activities
|
|||
|
Acquisition of intangible assets
|
–
|
–
|
(10,000)
|
|
Net Cash Used by Investing Activities
|
–
|
–
|
(10,000)
|
|
Financing activities
|
|||
|
Proceeds from loan payable
|
–
|
–
|
649,600
|
|
Repayment of loan payable
|
–
|
–
|
(149,449)
|
|
Proceeds from related parties
|
–
|
–
|
2,649
|
|
Repayment to related parties
|
–
|
–
|
(25,000)
|
|
Capital contribution
|
–
|
–
|
200,600
|
|
Proceeds from the issuance of common stock
|
–
|
–
|
7,523
|
|
Net Cash Provided by Financing Activities
|
–
|
–
|
685,923
|
|
Increase (decrease) in Cash
|
(112,616)
|
(28,977)
|
207,562
|
|
Cash, Beginning of Period
|
320,178
|
33,034
|
–
|
|
Cash, End of Period
|
207,562
|
4,057
|
207,562
|
|
Supplemental Disclosures
|
|||
|
Interest paid
|
–
|
–
|
–
|
|
Income tax paid
|
–
|
–
|
–
|
|
Non-cash investing and financing activities
|
|||
|
Forgiveness of related party debt
|
–
|
–
|
2,649
|
|
Issuance of common shares for acquisition of assets
|
–
|
–
|
250,000
|
|
Issuance of preferred shares for acquisition of assets
|
–
|
–
|
7,500
|
|
Issuance of note payable for acquisition of assets
|
–
|
–
|
325,000
|
|
1.
|
Nature of Operations and Continuance of Business
|
|
2.
|
Summary of Significant Accounting Policies
|
|
|
a)
|
Basis of Presentation
|
|
|
b)
|
Use of Estimates
|
|
|
c)
|
Cash and Cash Equivalents
|
|
|
d)
|
Beneficial Conversion Features
|
|
2.
|
Summary of Significant Accounting Policies
(continued)
|
|
|
h)
|
Comprehensive Loss
|
|
|
i)
|
Financial Instruments
|
|
2.
|
Summary of Significant Accounting Policies
(continued)
|
|
|
i)
|
Financial Instruments (continued)
|
|
Fair Value Measurements Using
|
||||
|
Quoted prices in active
markets for identical
instruments
(Level 1)
$
|
Significant other
observable inputs
(Level 2)
$
|
Significant
unobservable inputs
(Level 3)
$
|
Balance,
March 31, 2012
$
|
|
|
Convertible debenture
|
–
|
–
|
490,074
|
490,074
|
|
|
j)
|
Recent Accounting Pronouncements
|
|
2.
|
Summary of Significant Accounting Policies
(continued)
|
|
|
j)
|
Recent Accounting Pronouncements (continued)
|
|
a)
|
As at March 31, 2012, the Company owes $319,616 (December 31, 2011 - $312,137) to a company controlled by officers and directors of the Company. The amounts owing are unsecured, bears interest at 10% per annum, and due by August 15, 2012. As at March 31, 2012, the Company has recorded accrued interest of $19,616.
|
|
b)
|
As at March 31, 2012, the Company owes $3,000 (December 31, 2011 - $nil) to the President and CEO of the Company for unpaid consulting fees and reimbursement of expenses paid on behalf of the Company.
|
|
c)
|
As of March 31, 2012, the Company paid $9,000 (December 31, 2011 - $9,000) to the President and CEO of the Company for consulting services.
|
|
a)
|
On October 12, 2011, the Company entered into a verbal consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. During the three months ended March 31, 2012, the Company incurred and paid $9,000 in consulting fees relating to this agreement.
|
|
b)
|
On October 12, 2011, the Company entered into a verbal consulting agreement with a non-related party whereby the Company will pay a monthly consulting fee for services provided in the amounts of $27,500. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. During the three month period ended March 31, 2012, the Company incurred and paid $82,500 in consulting fees relating to this agreement.
|
|
c)
|
On October 12, 2011, the Company entered into a verbal consulting agreement with the President and CEO of the Company whereby the Company will pay a monthly consulting fee for services provided in the amounts of $3,000. The agreement is for a one month term automatically renewing in each successive month unless earlier terminated. During the three months ended March 31, 2012, the Company incurred $9,000 and paid $6,000 in consulting fees relating to this agreement.
|
|
|
March 31,
2012
$
|
December 31,
2011
$
|
|
Current Assets
|
213,314
|
327,753
|
|
Current Liabilities
|
341,364
|
318,646
|
|
Working Capital (Deficit)
|
(128,050)
|
9,107
|
|
|
March 31,
2012
$
|
March 31,
2011
$
|
|
Cash Flows from (used in) Operating Activities
|
(112,616)
|
(28,977)
|
|
Net Increase (decrease) in Cash During Period
|
(112,616)
|
(28,977)
|
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
|
HDS INTERNATIONAL CORP.
|
||
|
(the “Registrant”)
|
||
|
BY:
|
TASSOS RECACHINAS
|
|
|
Tassos Recachinas
|
||
|
President
|
||
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|